Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: Central nervous system

December 19, 2025 CD derivatives / Pharma applications

Cyclodextrin-based carriers for targeted drug delivery, a new review

This post was written by Ibrahim Hussein. Cyclodextrin-based carriers have evolved beyond their traditional role as solubilizing agents toward ligand-targeted,

Continue reading

October 20, 2025 CD as API / Pharma applications

Cholesterol in the CNS: functions, recycling and remyelination

The central nervous system ( CNS) is increasingly recognized as a cholesterol-rich organ. While the brain accounts for approximately 5%

Continue reading

September 13, 2021 CD as API / Pharma applications

Think Big, Start Small: How Nanomedicine Could Alleviate the Burden of Rare CNS Diseases

The complexity and organization of the central nervous system (CNS) is widely modulated by the presence of the blood–brain barrier

Continue reading

April 21, 2021 CD as API / Drug delivery / Pharma applications

Central nervous system delivery of molecules across the blood-brain barrier

Therapies targeting neurological conditions such as Alzheimer’s or Parkinson’s diseases are hampered by the presence of the blood-brain barrier (BBB).

Continue reading

Recent Posts

  • Cyclodextrin-Based Oral Solution of Ursodeoxycholic Acid Using a Ready-to-Use Vehicle
  • Cyclodextrin-based electrochemical sensors for PFAS detection
  • FDA: Inclusion complex of a GRAS guest and a GRAS host is also GRAS
  • HPBCD for the treatment of irreversible white matter injury
  • Deadline for early bird registration to ICS-22: 31 July

Tags

alpha-CD Alzheimer disease atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (27)
  • Analysis (72)
  • CD as API (350)
  • CD derivatives (422)
  • Cosmetics and toilettry (52)
  • Diagnosis (13)
  • Drug delivery (803)
  • E-ducation (63)
  • Environmental (140)
  • Events (236)
  • Food (229)
  • Gene delivery (22)
  • Household products (1)
  • Household products (5)
  • In Hungarian (4)
  • Life sciences (44)
  • Non-pharma applications (408)
  • Other industrial use (110)
  • Pharma applications (1,199)
  • Supramolecular systems (44)
  • Uncategorized (160)

Top Posts

  • Cyclodextrin-Based Oral Solution of Ursodeoxycholic Acid Using a Ready-to-Use Vehicle
  • FDA Grants Approval to HPBCD-Enhanced Biologic: A 'Super-Originator' Formulation
  • Cyclarity Unveils First-Ever Clinical Data Demonstrating Excretion of Oxidized Cholesterol, at American Heart Association Vascular Discovery Scientific Sessions
  • Effects of β-cyclodextrin bead polymer on the quality of wines
  • FDA: Inclusion complex of a GRAS guest and a GRAS host is also GRAS
  • Lanosterol eye drops for cataract treatment
  • Cyclodextrin-based electrochemical sensors for PFAS detection
  • Application of cyclodextrins for detoxification purposes and/or as antidotes: Still more questions than answers
  • Solvent-free cyclodextrin nanosponges complexes for increasing the bioavailability
  • Advanced Functional Materials Congress

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,475 other subscribers

Loading Comments...